Tag: oncology

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that regulatory submissions based on the ...

U.S. Food and Drug Administration approved Opdivo (nivolumab), in combination with certain types of chemotherapy, for ...

– Promising preclinical data suggest best-in-class potential for XB002, a next-generation tissue factor-targeting antibody-drug conjugate – ...

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca today announced the first patient was dosed ...

If approved, Opdivo would be the first adjuvant immunotherapy option for patients with muscle-invasive urothelial carcinoma in ...

Recommendation is based on the Phase III IMpower110 study showing that Tecentriq significantly improved overall survival ...

Alkem Laboratories Limited ("Alkem") has agreed to partner with Tata Memorial Centre ("TMC") to establish an ...